Literature DB >> 3035067

Respiratory virus infection of peripheral blood monocytes: correlation with ageing of cells and interferon production in vitro.

L R Krilov, R M Hendry, E Godfrey, K McIntosh.   

Abstract

The ability of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) to replicate in peripheral blood monocytes cultured in vitro for 1, 2, 4 or 7 days prior to infection was investigated. Inoculation of 1-day old monocytes produced at least tenfold less new virus than infection of the older, more macrophage-like cells for both viruses. PIV3 induced extensive syncytium formation, whereas RSV caused a cytopathic effect manifest by increased rounding of the cells with minimal syncytium formation. Supernatants of infected monocytes were assayed for human interferon-alpha (HuIFN-alpha) in an attempt to explain the restricted viral replication in the youngest monocytes. In PIV3-infected cells, HuIFN-alpha production was inversely correlated with new virus formation. Monocytes infected after 1 day in culture produced 800 IU/ml of HuIFN-alpha; the older cells produced 100 to 200 IU/ml. In contrast, monocytes infected on day 1 with RSV produced minimal amounts (1.5 IU/ml) of HuIFN-alpha. Increasing amounts of HuIFN-alpha were detected in cells infected with RSV after 2, 4 or 7 days in culture, reaching a maximum of 400 IU/ml on day 7. Further investigation of the apparent restriction of replication in young monocyte cultures may be helpful in understanding the pathogenesis of these respiratory infections.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035067     DOI: 10.1099/0022-1317-68-6-1749

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 2.  Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.

Authors:  J B Domachowske; H F Rosenberg
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

3.  Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide.

Authors:  Yun-Chi Chen; Sheng-Yuan Wang
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Productive infection of isolated human alveolar macrophages by respiratory syncytial virus.

Authors:  J R Panuska; N M Cirino; F Midulla; J E Despot; E R McFadden; Y T Huang
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

5.  Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection.

Authors:  R Arnold; B König; H Galatti; H Werchau; W König
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

6.  Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins.

Authors:  Jean-Francois Valarcher; Julie Furze; Sara Wyld; Roy Cook; Karl-Klaus Conzelmann; Geraldine Taylor
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants.

Authors:  C Osiowy; D Horne; R Anderson
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

8.  GBP5 Is an Interferon-Induced Inhibitor of Respiratory Syncytial Virus.

Authors:  Zhaolong Li; Xinglong Qu; Xin Liu; Chen Huan; Hong Wang; Zhilei Zhao; Xu Yang; Shucheng Hua; Wenyan Zhang
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

9.  Retinoic acid inducible gene I activates innate antiviral response against human parainfluenza virus type 3.

Authors:  Ahmed Sabbah; Santanu Bose
Journal:  Virol J       Date:  2009-11-17       Impact factor: 4.099

10.  Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes.

Authors:  Alpana Waghmare; Angela P Campbell; Hu Xie; Sachiko Seo; Jane Kuypers; Wendy Leisenring; Keith R Jerome; Janet A Englund; Michael Boeckh
Journal:  Clin Infect Dis       Date:  2013-09-24       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.